<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">12814758</PMID>
      <DateCompleted>
        <Year>2003</Year>
        <Month>10</Month>
        <Day>27</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>05</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1297-319X</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>70</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2003</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Joint bone spine</Title>
          <ISOAbbreviation>Joint Bone Spine</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Antisynthetase syndrome.</ArticleTitle>
        <Pagination>
          <StartPage>161</StartPage>
          <EndPage>168</EndPage>
          <MedlinePgn>161-8</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Seven autoantibodies directed against synthetases have been identified to date, the best known being anti-Jo1. Synthetases play a vital role in protein synthesis by catalyzing the acetylation of transfer RNAs (tRNAs). The most common form of antisynthetase syndrome is characterized by anti-Jo1 production, interstitial lung disease (ILD), inflammatory muscle disease, and, in many cases, fever, polyarthritis, Raynaud's phenomenon, and thick cracked skin on the fingers (mechanic's hands). The interstitial lung disease is generally of the "usual interstitial pneumopathy" type and shares similarities with idiopathic pulmonary fibrosis or scleroderma-related pulmonary disease. It governs the prognosis of the disease, being associated with an excess mortality rate of about 40%. The pathogenic mechanisms underlying antisynthetase syndrome remain unknown but may involve cell-mediated immunity. The treatment is not standardized. The ILD responds to glucocorticoids in some patients but requires other immunosuppressant drugs in others.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Imbert-Masseau</LastName>
            <ForeName>Agathe</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Internal Medicine Department A, Hôtel-Dieu, Nantes Teaching Hospital, 1 place Alexis Ricordeau, 44093, Nantes, France. agathe.masseau@caramail.com</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hamidou</LastName>
            <ForeName>Mohamed</ForeName>
            <Initials>M</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Agard</LastName>
            <ForeName>Christian</ForeName>
            <Initials>C</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Grolleau</LastName>
            <ForeName>Jean Yves</ForeName>
            <Initials>JY</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chérin</LastName>
            <ForeName>Pascal</ForeName>
            <Initials>P</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>France</Country>
        <MedlineTA>Joint Bone Spine</MedlineTA>
        <NlmUniqueID>100938016</NlmUniqueID>
        <ISSNLinking>1297-319X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000974">Antibodies, Antinuclear</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C046750">Jo-1 antibody</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 6.-</RegistryNumber>
          <NameOfSubstance UI="D008025">Ligases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000974" MajorTopicYN="Y">Antibodies, Antinuclear</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001327" MajorTopicYN="N">Autoimmune Diseases</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008025" MajorTopicYN="N">Ligases</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <NumberOfReferences>82</NumberOfReferences>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2003</Year>
          <Month>6</Month>
          <Day>20</Day>
          <Hour>5</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2003</Year>
          <Month>10</Month>
          <Day>28</Day>
          <Hour>5</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2003</Year>
          <Month>6</Month>
          <Day>20</Day>
          <Hour>5</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">12814758</ArticleId>
        <ArticleId IdType="doi">10.1016/s1297-319x(03)00012-5</ArticleId>
        <ArticleId IdType="pii">S1297319X03000125</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
